RxDoctor Payments Data

Analyn Holman

Acute Care · Mesa, AZNPI 1972041390

Payments from drug & device makers

$2,673in general payments, 2019–2025

Across 112 payments — averaging $23.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$635
  • Merck$385
  • Abbott$228
  • Impulse Dynamics (USA) Inc.$201
  • Sanofi-aventis U.S. LLC$176
  • Medtronic$155
  • plus $894 from 19 others

What the payments were for

  • Food & beverage$2,63499%
  • Other$391%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,673 in reported general payments places this provider in the 80th percentile of 482 acute care providers in Arizona.

See all acute care providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban301$398,575
EntrestoSacubitril/Valsartan82$126,400
XareltoRivaroxaban99$118,042
FarxigaDapagliflozin Propanediol64$78,797
JardianceEmpagliflozin18$30,992
Repatha SureclickEvolocumab26$26,465
BrilintaTicagrelor18$19,169
Praluent PenAlirocumab21$13,679
Ranolazine ErRanolazine58$6,614
Metoprolol Succinate318$4,899
Isosorbide Mononitrate ErIsosorbide Mononitrate179$3,403
Amiodarone Hcl90$3,059
ClopidogrelClopidogrel Bisulfate222$2,970
Clonidine12$2,743
Nebivolol Hcl26$2,568

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$108$398,575301 claims
NovartisEntresto$635$126,40082 claims
Johnson & JohnsonXarelto$56$118,04299 claims
Boehringer IngelheimJardiance$143$30,99218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 482 acute care providers in Arizona.

Other acute care in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →